Published in Arthritis Rheum on February 15, 2007
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum (2009) 1.21
Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol (2014) 0.90
The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients. Rheumatol Int (2015) 0.84
Can Behcet's Disease Related Pulmonary Arterial Aneurysms be Completely Resolved? Open Rheumatol J (2011) 0.83
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol (2016) 0.79
Prevalence of Behcet's disease among adult patients consulting three major clinics in a Druze town in Israel. Clin Rheumatol (2010) 0.79
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol (2016) 0.77
Lack of association of two polymorphisms of IRF5 with Behcet's disease. Mol Vis (2009) 0.77
New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients. Auto Immun Highlights (2013) 0.77
Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies. Dermatology (2016) 0.76
A Case of Neuro-Behcet's Disease Presenting with Central Neurogenic Hyperventilation. Am J Case Rep (2016) 0.75
Update on the diagnosis and management of Behçet's disease. Open Access Rheumatol (2014) 0.75
Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide. Int J Dermatol (2016) 0.75
Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med (2002) 7.05
Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol (2009) 3.53
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med (2007) 2.27
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology (2003) 1.96
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med (2002) 1.86
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum (2007) 1.76
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res (Hoboken) (2010) 1.70
Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol (2006) 1.69
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) (2009) 1.60
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) (2009) 1.49
Phase-contrast cine MRI revealing en valve mechanism in spontaneous third ventriculostomy: report of a case and literature review. Clin Neurol Neurosurg (2010) 1.47
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) (2011) 1.45
Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis (2006) 1.43
Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol (2014) 1.43
An unusual cause of dysphagia. J Rheumatol (2012) 1.38
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum (2005) 1.29
Ileal pouchitis-related arthritis. Semin Arthritis Rheum (2002) 1.23
Enthesitis. Best Pract Res Clin Rheumatol (2006) 1.21
Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol (2012) 1.20
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol (2012) 1.18
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum (2005) 1.18
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol (2011) 1.15
Polymyalgia rheumatica. Best Pract Res Clin Rheumatol (2004) 1.11
Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol (2007) 1.09
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd (2002) 1.08
Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis? J Rheumatol (2013) 1.05
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol (2002) 1.02
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis (2010) 1.02
Hepatitis C virus-related arthritis. Autoimmun Rev (2008) 1.02
New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol (2006) 1.01
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol (2014) 1.00
Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum (2004) 0.98
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol (2009) 0.96
Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum (2003) 0.96
PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford) (2012) 0.95
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Arthritis Rheum (2006) 0.95
Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol (2006) 0.94
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol (2008) 0.94
Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J Rheumatol (2006) 0.93
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis (2012) 0.93
Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine (2010) 0.92
Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol (2003) 0.92
Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum (2013) 0.92
Idiopathic aortitis: an underrecognized vasculitis. Arthritis Res Ther (2011) 0.91
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol (2002) 0.91
Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis (2013) 0.90
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol (2011) 0.90
Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol (2011) 0.90
Cogan syndrome. Cornea (2002) 0.90
Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers. Clin Exp Rheumatol (2012) 0.89
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum (2004) 0.89